{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:27:54Z","timestamp":1785788874962,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.nmd.2026.106414","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:17:17Z","timestamp":1774052237000},"page":"106414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessing biomarkers of bone metabolism and the role of the interleukin-6 signaling pathway in patients with Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7163-0075","authenticated-orcid":false,"given":"Maitea","family":"Guridi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"De Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Gee","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Scharke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6729-5841","authenticated-orcid":false,"given":"Nicola","family":"Crabtree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio M.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh J.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2026.106414_bib0001","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40120-023-00570-w","article-title":"The clinical development of Taldefgrobep Alfa: an anti-myostatin adnectin for the treatment of duchenne muscular dystrophy","volume":"13","author":"Muntoni","year":"2024","journal-title":"Neurol Ther"},{"issue":"4","key":"10.1016\/j.nmd.2026.106414_bib0002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mus.26416","article-title":"Muscle function and age are associated with loss of bone mineral density in Duchenne muscular dystrophy","volume":"59","author":"Del Roc\u00edo Cruz-Guzm\u00e1n","year":"2019","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.nmd.2026.106414_bib0003","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/jbmr.410","article-title":"Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans","volume":"26","author":"Rufo","year":"2011","journal-title":"J Bone Min Res"},{"issue":"11\u201312","key":"10.1016\/j.nmd.2026.106414_bib0004","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.nmd.2007.05.008","article-title":"Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy","volume":"17","author":"S\u00f6derpalm","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2026.106414_bib0005","first-page":"77","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"LancetNeurology"},{"key":"10.1016\/j.nmd.2026.106414_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bonekey.2012.5","article-title":"Insights into bone health in duchenne muscular dystrophy","volume":"1","author":"Morgenroth","year":"2012","journal-title":"Bonekey Rep"},{"issue":"10","key":"10.1016\/j.nmd.2026.106414_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101366","article-title":"Inflammation in Duchenne muscular dystrophy-exploring the role of neutrophils in muscle damage and regeneration","volume":"9","author":"Tulangekar","year":"2021","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.nmd.2026.106414_bib0008","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.41666","article-title":"Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis","volume":"73","author":"Yokota","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.nmd.2026.106414_bib0009","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40618-021-01676-4","article-title":"Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates","volume":"45","author":"Catalano","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.nmd.2026.106414_bib0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nmd.2017.05.012","article-title":"Proceedings of a parent project Muscular Dystrophy Bone Health Workshop: morbidity due to osteoporosis in DMD: the Path Forward May 12-13, 2016, Bethesda, Maryland, USA","volume":"28","author":"Ward","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2026.106414_bib0011","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12887-019-1503-x","article-title":"Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy","volume":"19","author":"Wood","year":"2019","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.nmd.2026.106414_bib0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MED.0000000000000456","article-title":"Growth, pubertal development, and skeletal health in boys with Duchenne Muscular Dystrophy","volume":"26","author":"Ward","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10","key":"10.1016\/j.nmd.2026.106414_bib0013","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jamaneurol.2022.2480","article-title":"Efficacy and safety of Vamorolone vs Placebo and Prednisone among boys with Duchenne muscular dystrophy: a randomized clinical trial","volume":"79","author":"Guglieri","year":"2022","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2026.106414_bib0014","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1093\/rheumatology\/keaf129","article-title":"Vamorolone: a novel metabolism resistant steroid that suppresses joint destruction in chronic polyarthritis with reduced systemic side effects","volume":"64","author":"Crastin","year":"2025","journal-title":"Rheumatol (Oxf)"},{"issue":"9","key":"10.1016\/j.nmd.2026.106414_bib0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/PHM.0000000000001423","article-title":"Retrospective analysis of fractures and factors causing ambulation loss after lower limb fractures in Duchenne muscular dystrophy","volume":"99","author":"Yildiz","year":"2020","journal-title":"Am J Phys Med Rehabil \/Assoc Acad Physiatr"},{"issue":"Suppl 2","key":"10.1016\/j.nmd.2026.106414_bib0016","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1542\/peds.2018-0333E","article-title":"Bone health and osteoporosis management of the patient with duchenne muscular dystrophy","volume":"142","author":"Ward","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.nmd.2026.106414_bib0017","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JND-230176","article-title":"Moving beyond the 2018 minimum international care considerations for osteoporosis management in Duchenne muscular dystrophy (DMD): meeting report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022","volume":"11","author":"Phung","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106414_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40364-017-0097-4","article-title":"Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives","volume":"5","author":"Kuo","year":"2017","journal-title":"Biomark Res"},{"issue":"5","key":"10.1016\/j.nmd.2026.106414_bib0019","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bone.2005.06.002","article-title":"Interleukin-6: an osteotropic factor influencing bone formation?","volume":"37","author":"Franchimont","year":"2005","journal-title":"Bone"},{"issue":"21","key":"10.1016\/j.nmd.2026.106414_bib0020","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1093\/hmg\/ddv323","article-title":"Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice","volume":"24","author":"Pelosi","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"W1","key":"10.1016\/j.nmd.2026.106414_bib0021","doi-asserted-by":"crossref","first-page":"W547","DOI":"10.1093\/nar\/gkaf394","article-title":"The UniProt website API: facilitating programmatic access to protein knowledge","volume":"53","author":"Ahmad","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.nmd.2026.106414_bib0022","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.nmd.2026.106414_bib0023","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jamaneurol.2019.0242","article-title":"Fractures and linear growth in a nationwide cohort of boys with duchenne muscular dystrophy with and without glucocorticoid treatment: results from the UK NorthStar Database","volume":"76","author":"Joseph","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2026.106414_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116248","article-title":"Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne muscular dystrophy (DMD)","volume":"154","author":"Crabtree","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.nmd.2026.106414_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/928385","article-title":"Optimizing bone health in Duchenne muscular dystrophy","volume":"2015","author":"Buckner","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"8","key":"10.1016\/j.nmd.2026.106414_bib0026","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/jbmr.3718","article-title":"Growth hormone increases bone toughness and decreases muscle inflammation in glucocorticoid-treated mdx mice, model of Duchenne muscular dystrophy","volume":"34","author":"Yoon","year":"2019","journal-title":"J Bone Min Res"},{"issue":"6","key":"10.1016\/j.nmd.2026.106414_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat rev Rheumatol"},{"key":"10.1016\/j.nmd.2026.106414_bib0028","article-title":"Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-\u03bab, ERK and JNK signaling pathways","volume":"7","author":"Feng","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.nmd.2026.106414_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102884","article-title":"Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis","volume":"20","author":"Takeuchi","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.nmd.2026.106414_bib0030","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","article-title":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17","volume":"47","author":"Hashizume","year":"2008","journal-title":"Rheumatol (Oxf)"},{"issue":"11","key":"10.1016\/j.nmd.2026.106414_bib0031","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1007\/s00018-021-03821-x","article-title":"Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy","volume":"78","author":"Starosta","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"15","key":"10.1016\/j.nmd.2026.106414_bib0032","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.2022.4315","article-title":"Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy: a randomized clinical trial","volume":"327","author":"Guglieri","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.nmd.2026.106414_bib0033","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00198-019-05077-5","article-title":"Evaluating RANKL and OPG levels in patients with Duchenne muscular dystrophy","volume":"30","author":"Akhtar Ali","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nmd.2026.106414_bib0034","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-025-07651-6","article-title":"Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review","author":"De Ford","year":"2025","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.nmd.2026.106414_bib0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","article-title":"Bone mineral density and bone metabolism in Duchenne muscular dystrophy","volume":"14","author":"Bianchi","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nmd.2026.106414_bib0036","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2147\/TCRM.S143317","article-title":"Fat embolism after fractures in Duchenne muscular dystrophy: an underdiagnosed complication? A systematic review","volume":"13","author":"Feder","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.nmd.2026.106414_bib0037","unstructured":"US Food & Drug Administration. FDA adverse events reporting system (FAERS) public dashboard. https:\/\/fis.fda.gov\/sense\/app\/95239e26-e0be-42d9-a960-9a5f7f1c25ee\/sheet\/7a47a261-d58b-4203-a8aa-6d3021737452\/state\/analysis.2025 [accessed February 2025]."},{"issue":"1","key":"10.1016\/j.nmd.2026.106414_bib0038","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13395-017-0140-z","article-title":"Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-\/utrophin-deficient mice","volume":"7","author":"Wada","year":"2017","journal-title":"Skelet Muscle"},{"issue":"4","key":"10.1016\/j.nmd.2026.106414_bib0039","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ebiom.2015.03.018","article-title":"IL-6 blockade as a therapeutic approach for duchenne muscular dystrophy","volume":"2","author":"Mammen","year":"2015","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.nmd.2026.106414_bib0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.30158","volume":"63","author":"Kremer","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.nmd.2026.106414_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48548-9","article-title":"Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy","volume":"9","author":"Hathout","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.nmd.2026.106414_bib0042","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jcsm.12304","article-title":"Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies","volume":"9","author":"Spitali","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.nmd.2026.106414_bib0043","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/03009742.2017.1416667","article-title":"Anti-interleukin-6 receptor antibody prevents loss of bone structure and bone strength in collagen-induced arthritis mice","volume":"47","author":"Yoshida","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.nmd.2026.106414_bib0044","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/annrheumdis-2015-eular.2637","article-title":"THU0061\u2005The effect of Anti-IL-6 receptor antibody on cartilage destruction in a mouse model of collagen-induced arthritis","volume":"74","author":"Suzuki","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.nmd.2026.106414_bib0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI118431","article-title":"Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation","volume":"97","author":"Zhu","year":"1996","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.nmd.2026.106414_bib0046","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000084844","article-title":"IL-6 and its circadian secretion in humans","volume":"12","author":"Vgontzas","year":"2005","journal-title":"Neuroimmunomodulation"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:13:40Z","timestamp":1777342420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896626000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S0960896626000829"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106414","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing biomarkers of bone metabolism and the role of the interleukin-6 signaling pathway in patients with Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106414"}}